Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Impact of Dexmedetomidine on Allograft Function Recovery and Survival Following Liver Transplantation: A Randomised Control Trial

NCT03770130 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT03770130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03770130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Impact of Dexmedetomidine on Allograft Function Recovery and Survival Following Liver Transplantation: A Randomised Control Trial
Lead sponsor
RenJi Hospital
Phase
Phase 1
Overall status
Completed
Start date
January 14, 2019
Completion date
December 31, 2022
Enrollment
330 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dexmedetomidine, liver transplantation, allograft function, survival